Medical Condition News

RSS

New book on managing worry, anxiety and fear

Americans' danger detectors are cranked up way too high these days, but we don't have to be held hostage by our anxiety, according to a new book on coping with stress by a Northwestern Medicine psychologist.

3 Dec 2010

Healthy lifestyle choices, emergency room interventions can help prevent first-time strokes

Healthy lifestyle choices and emergency room interventions can help prevent first-time strokes, according to revised American Heart Association/American Stroke Association guidelines.

3 Dec 2010

Obama praised for enhanced health care reform for Alzheimer's community

According to the Society of Actuaries, the leading cause of U.S. long-term care claims is Alzheimer's, the brain disease that renders over 5 million Americans unable to handle all the acts of daily living unaided. Who cares? Evidently President Obama does, having written a pro-active column in the Fall, 2010, issue of care ADvantage, published by the Alzheimer's Foundation of America.

3 Dec 2010

3M announces availability of TLR compounds for nonvaccine use in pharmaceutical industry

3M announces the availability of immune response modifier compounds for nonvaccine use in the pharmaceutical industry. The toll-like receptor (TLR) compounds, that activate through TLR7 and TLR8, show promise for the treatment of conditions including cancer, dermatologic diseases and atopic diseases, such as allergy and asthma.

3 Dec 2010

CRT therapy is cost-effective for symptomatic heart failure patients: REVERSE trial

Medtronic, Inc. announced findings from an economic sub-study of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial published in the European Heart Journal demonstrating for the first time that cardiac resynchronization therapy (CRT) is cost-effective in mildly symptomatic heart failure (HF) patients.

3 Dec 2010

Scripps scientists find way to transform mature human cells into stem cells

Scripps Research Institute scientists have made a significant leap forward in the drive to find a way to safely reprogram mature human cells and turn them into stem cells, which can then change into other cell types, such as nerve, heart, and liver cells. The ability to transform fully mature adult cells such as skin cells into stem cells has potentially profound implications for treating many diseases.

3 Dec 2010

New robotic arm device for early to mid-stage osteoarthritis

A robotic arm device developed to assist orthopedic surgeons with performing partial knee replacement surgery for early to mid-stage osteoarthritis is now available at NewYork-Presbyterian Hospital/Columbia University Medical Center. The technology was approved by the FDA in 2005, and to date nearly 5,000 cases have been performed in the U.S.

3 Dec 2010

Cell Therapeutics submits pixantrone NDA application to treat non-Hodgkin's lymphoma

Cell Therapeutics, Inc. today announced that it has submitted a formal appeal to the Office of New Drugs in the U.S. Food and Drug Administration's Center for Drug Evaluation and Research regarding the agency's decision from earlier this year on the pixantrone New Drug Application to treat relapsed/refractory aggressive non-Hodgkin's lymphoma.

3 Dec 2010

UCLA findings could lead to enhanced health supplements, progress on Parkinson's

The discovery by UCLA biochemists of a new method for preventing oxidation in the essential fatty acids of cell membranes could lead to a new class of more effective nutritional supplements and potentially help combat neurodegenerative disorders such as Parkinson's disease and perhaps Alzheimer's.

3 Dec 2010

Arthritis drug reduces incidence of non-melanoma skin cancers

A widely-used arthritis drug reduces the incidence of non-melanoma skin cancers - the most common cancers in humans - according to a study published this week in the Journal of the National Cancer Institute. The COX-2 inhibitor celecoxib (brand name Celebrex), which is currently approved for the treatment of osteoarthritis, rheumatoid arthritis and acute pain in adults led to a 62 percent reduction in non-melanoma skin cancers, which includes basal cell carcinomas and squamous cell carcinomas.

3 Dec 2010

Sagent launches chemotherapy agent topotecan hydrochloride for injection

Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced U.S. FDA approval and launch of its topotecan hydrochloride for injection, a chemotherapy agent, in conjunction with the innovator's patent expiry. Sagent's topotecan is available in 4 mg single-dose latex-free vials.

3 Dec 2010

Sentara Heart Hospital commences procedures in AtriCure DEEP AF feasibility trial

Sentara Heart Hospital is breaking new ground in cardiac care and treatment. Surgeons and Cardiologists at Sentara Heart Hospital are first to begin enrolling and performing trial cases in the AtriCure DEEP AF feasibility trial. The first procedure in the country was performed in a new, state-of-the-art hybrid operating room at Sentara Heart Hospital by Jonathan Philpott, M.D., Director of the Sentara Atrial Fibrillation Surgery Program, Ian Woollett, M.D., and John Onufer, M.D., Medical Director of Cardiac Electrophysiology.

3 Dec 2010

Dysfunction in blood vessels plays a role in Alzheimer's disease development

A dysfunction in the lining of blood vessels that is linked to cardiovascular illness also appears to play a role in the development of Alzheimer's disease, according to a study published in Circulation Research: Journal of the American Heart Association.

3 Dec 2010

TITAN Modular Total Shoulder System implantation performed at Bucks County Specialty Hospital

Ascension Orthopedics, Inc., the world leader in PyroCarbon orthopedic devices, announces another implantation of the TITAN™ Modular Total Shoulder. The surgery was performed by Matthew Ramsey, M.D. at Bucks County Specialty Hospital in Bensalem, Pennsylvania.

3 Dec 2010

AHA: Incidence of hospitalization for heart valve diseases rises in New York

The incidence of hospitalization and treatment for heart valve diseases in New York State has constantly and progressively risen since the early 1980s, according to research presented at the recent meeting of the American Heart Association (AHA) by SUNY Downstate Medical Center. The study results were published in a supplement to the AHA journal, Circulation.

3 Dec 2010

CDC: Hip replacement surgical procedures are more prevalent in the U.S.

According to the Centers for Disease Control and Prevention (CDC), hip replacements are among the most common surgical procedures in the United States; and with osteoarthritis and obesity on the rise, demand for the procedure is expected to grow.

3 Dec 2010

Indiana University to join multi-state program focused on cervical cancer prevention

Indiana will join a multi-state program focused on cervical cancer prevention thanks to an unrestricted gift from GlaxoSmithKline Pharmaceuticals to the Indiana University School of Medicine, in partnership with the Kristen Forbes EVE Foundation.

3 Dec 2010

MU nanomedicine experts form new partnership with Shasun Pharmaceuticals

University of Missouri leaders celebrated a nanomedicine milestone today as they announced the creation of a new drug development company. The new company forms a partnership between university researchers and an international pharmaceutical firm to advance testing of a potential cancer treatment created at MU.

3 Dec 2010

Quebec Foundation invests $5 million for breast cancer research

Thanks to Quebecers' generosity and the many fundraising activities organized over the last two years, the Quebec Breast Cancer Foundation is proud to announce a new strategic funding competition, through which it will invest up to $5 million in Quebec for breast cancer research.

3 Dec 2010

Alcohol drinking pattern impacts coronary heart disease

A fascinating study published in the BMJ shows that although the French drink more than the Northern Irish each week, as they drink daily, rather than more on less occasions, the French suffered from considerably less coronary heart disease than the Northern Irish.

3 Dec 2010

Medical Condition News

New book on managing worry, anxiety and fear

Healthy lifestyle choices, emergency room interventions can help prevent first-time strokes

Obama praised for enhanced health care reform for Alzheimer's community

3M announces availability of TLR compounds for nonvaccine use in pharmaceutical industry

CRT therapy is cost-effective for symptomatic heart failure patients: REVERSE trial

Scripps scientists find way to transform mature human cells into stem cells

New robotic arm device for early to mid-stage osteoarthritis

Cell Therapeutics submits pixantrone NDA application to treat non-Hodgkin's lymphoma

UCLA findings could lead to enhanced health supplements, progress on Parkinson's

Arthritis drug reduces incidence of non-melanoma skin cancers

Sagent launches chemotherapy agent topotecan hydrochloride for injection

Sentara Heart Hospital commences procedures in AtriCure DEEP AF feasibility trial

Dysfunction in blood vessels plays a role in Alzheimer's disease development

TITAN Modular Total Shoulder System implantation performed at Bucks County Specialty Hospital

AHA: Incidence of hospitalization for heart valve diseases rises in New York

CDC: Hip replacement surgical procedures are more prevalent in the U.S.

Indiana University to join multi-state program focused on cervical cancer prevention

MU nanomedicine experts form new partnership with Shasun Pharmaceuticals

Quebec Foundation invests $5 million for breast cancer research

Alcohol drinking pattern impacts coronary heart disease

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Latest News